Guanhao Biotech Co.,Ltd. (300238.SZ)
CNY 13.98
(-1.48%)
CNY 13.98
(-1.48%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 62.87 Million CNY | 2.19% |
| 2022 | -234.75 Million CNY | -49.77% |
| 2021 | 146.15 Million CNY | 40.76% |
| 2020 | 97.72 Million CNY | 554.71% |
| 2019 | -418.59 Million CNY | -119.93% |
| 2018 | 116.51 Million CNY | -6.26% |
| 2017 | 112.31 Million CNY | 20.07% |
| 2016 | 93.15 Million CNY | -2.59% |
| 2015 | 101.65 Million CNY | 55.85% |
| 2014 | 62.92 Million CNY | 37.56% |
| 2013 | 48.65 Million CNY | 36.76% |
| 2012 | 33.74 Million CNY | -20.77% |
| 2011 | 42.07 Million CNY | 0.54% |
| 2010 | 40.15 Million CNY | 132.6% |
| 2009 | 17.1 Million CNY | 89.42% |
| 2008 | 8.98 Million CNY | 216.05% |
| 2007 | 3.03 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 20.89 Million CNY | 6669.16% |
| 2024 Q2 | 11.43 Million CNY | -55.54% |
| 2024 Q3 | 5.6 Million CNY | -53.26% |
| 2023 Q2 | 6.39 Million CNY | -78.05% |
| 2023 FY | - CNY | 2.19% |
| 2023 Q4 | -410.33 Thousand CNY | -102.31% |
| 2023 Q1 | 29.13 Million CNY | 313.15% |
| 2023 Q3 | 17.79 Million CNY | 178.27% |
| 2022 Q1 | 30.05 Million CNY | 35.44% |
| 2022 Q4 | -13.66 Million CNY | -272.53% |
| 2022 Q2 | 11.97 Million CNY | -60.17% |
| 2022 Q3 | 7.92 Million CNY | -33.82% |
| 2022 FY | - CNY | -49.77% |
| 2021 Q4 | 22.18 Million CNY | -6.13% |
| 2021 Q3 | 23.63 Million CNY | -13.5% |
| 2021 Q2 | 27.32 Million CNY | 4.9% |
| 2021 Q1 | 26.05 Million CNY | 1277.71% |
| 2021 FY | - CNY | 40.76% |
| 2020 Q3 | 19.21 Million CNY | -38.08% |
| 2020 FY | - CNY | 554.71% |
| 2020 Q4 | 1.89 Million CNY | -90.16% |
| 2020 Q2 | 31.03 Million CNY | 75.05% |
| 2020 Q1 | 17.72 Million CNY | 119.36% |
| 2019 Q3 | 22.11 Million CNY | 5370.69% |
| 2019 FY | - CNY | -119.93% |
| 2019 Q1 | 17.09 Million CNY | -57.57% |
| 2019 Q4 | -91.56 Million CNY | -514.01% |
| 2019 Q2 | -419.62 Thousand CNY | -102.45% |
| 2018 Q3 | 27.5 Million CNY | 340.95% |
| 2018 Q4 | 40.29 Million CNY | 46.48% |
| 2018 FY | - CNY | -6.26% |
| 2018 Q2 | 6.23 Million CNY | -27.82% |
| 2018 Q1 | 8.64 Million CNY | -61.05% |
| 2017 FY | - CNY | 20.07% |
| 2017 Q1 | 14.99 Million CNY | -59.76% |
| 2017 Q2 | 20.61 Million CNY | 37.43% |
| 2017 Q3 | 33.72 Million CNY | 63.62% |
| 2017 Q4 | 22.19 Million CNY | -34.2% |
| 2016 Q4 | 37.26 Million CNY | 110.04% |
| 2016 FY | - CNY | -2.59% |
| 2016 Q2 | 14.13 Million CNY | 81.68% |
| 2016 Q1 | 7.77 Million CNY | -83.59% |
| 2016 Q3 | 17.74 Million CNY | 25.56% |
| 2015 Q4 | 47.4 Million CNY | 250.09% |
| 2015 FY | - CNY | 55.85% |
| 2015 Q3 | 13.54 Million CNY | 92.24% |
| 2015 Q2 | 7.04 Million CNY | -18.23% |
| 2015 Q1 | 8.61 Million CNY | -57.43% |
| 2014 Q3 | 11.78 Million CNY | 111.98% |
| 2014 Q4 | 20.23 Million CNY | 71.69% |
| 2014 FY | - CNY | 37.56% |
| 2014 Q1 | 7.94 Million CNY | -50.58% |
| 2014 Q2 | 5.56 Million CNY | -30.04% |
| 2013 Q3 | 7.12 Million CNY | 44.36% |
| 2013 Q2 | 4.93 Million CNY | -17.58% |
| 2013 Q1 | 5.98 Million CNY | 71.35% |
| 2013 FY | - CNY | 36.76% |
| 2013 Q4 | 16.08 Million CNY | 125.72% |
| 2012 Q1 | 13.68 Million CNY | -31.74% |
| 2012 Q2 | 5.73 Million CNY | -58.08% |
| 2012 Q3 | 2.29 Million CNY | -59.96% |
| 2012 Q4 | 3.49 Million CNY | 52.08% |
| 2012 FY | - CNY | -20.77% |
| 2011 FY | - CNY | 0.54% |
| 2011 Q2 | 10.37 Million CNY | 472.53% |
| 2011 Q3 | 8.34 Million CNY | -19.57% |
| 2011 Q4 | 20.05 Million CNY | 140.3% |
| 2011 Q1 | 1.81 Million CNY | -91.31% |
| 2010 FY | - CNY | 132.6% |
| 2010 Q2 | 8.05 Million CNY | 589.32% |
| 2010 Q3 | 10.49 Million CNY | 30.34% |
| 2010 Q4 | 20.85 Million CNY | 98.7% |
| 2010 Q1 | -1.64 Million CNY | 0.0% |
| 2009 FY | - CNY | 89.42% |
| 2008 FY | - CNY | 216.05% |
| 2007 FY | - CNY | 0.0% |